Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.7.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KB.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HF.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.42.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.517NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.427 (Epsilon)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.429 (Epsilon)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.166NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.493NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.351.2 (Beta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.640.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.352NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.251NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCJNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FT.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FZ.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.574NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.355NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
GA.7.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.403NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.40NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.367NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.3.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.385NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.45NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.244NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.17.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.7.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.10.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KG.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HA.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used